Researchers looking into recovery-focused signalling pathways may also compare products from our Repair & Recovery Research category when studying broader recovery-oriented laboratory models
Geriatrics Pharmacokinetic and pharmacodynamic response of TRESIBA was compared in 13 younger adult (1835 years) and 14 geriatric (65 years) subjects with type 1 diabetes following two 6 day periods of once daily subcutaneous dosing with 0.4 units/kg dose of TRESIBA or insulin glargine
[11] Basen-Engquist, K., & Chang, M
Soft-necked garlic (data dump 06/29/2017, ID=880, 2017)
EMBO J 27:12661276 Lagirand-Cantaloube J, Cornille K, Csibi A, Batonnet-Pichon S, Leibovitch MP, Leibovitch SA (2009) Inhibition of atrogin-1/MAFbx mediated MyoD proteolysis prevents skeletal muscle atrophy in vivo